nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC2—epilepsy syndrome	0.134	0.444	CbGaD
Lamivudine—ABCG2—epilepsy syndrome	0.118	0.393	CbGaD
Lamivudine—ABCB1—epilepsy syndrome	0.0492	0.163	CbGaD
Lamivudine—ABCC3—Phenobarbital—epilepsy syndrome	0.0491	0.148	CbGbCtD
Lamivudine—ABCC2—Levetiracetam—epilepsy syndrome	0.0486	0.147	CbGbCtD
Lamivudine—ABCC1—Phenobarbital—epilepsy syndrome	0.0302	0.091	CbGbCtD
Lamivudine—ABCC2—Carbamazepine—epilepsy syndrome	0.0279	0.0843	CbGbCtD
Lamivudine—ABCC2—Phenytoin—epilepsy syndrome	0.0251	0.0756	CbGbCtD
Lamivudine—SLC22A1—Midazolam—epilepsy syndrome	0.0234	0.0707	CbGbCtD
Lamivudine—ABCC2—Phenobarbital—epilepsy syndrome	0.0223	0.0674	CbGbCtD
Lamivudine—SLC22A6—Acetazolamide—epilepsy syndrome	0.0163	0.0493	CbGbCtD
Lamivudine—ABCB1—Levetiracetam—epilepsy syndrome	0.0159	0.0478	CbGbCtD
Lamivudine—SLC22A6—Valproic Acid—epilepsy syndrome	0.0122	0.0368	CbGbCtD
Lamivudine—ABCB1—Clobazam—epilepsy syndrome	0.011	0.0332	CbGbCtD
Lamivudine—ABCB1—Lamotrigine—epilepsy syndrome	0.0106	0.0319	CbGbCtD
Lamivudine—ABCB1—Carbamazepine—epilepsy syndrome	0.00911	0.0275	CbGbCtD
Lamivudine—ABCB1—Phenytoin—epilepsy syndrome	0.00817	0.0246	CbGbCtD
Lamivudine—ABCB1—Phenobarbital—epilepsy syndrome	0.00728	0.022	CbGbCtD
Lamivudine—ABCB1—Midazolam—epilepsy syndrome	0.00718	0.0217	CbGbCtD
Lamivudine—ABCB1—Diazepam—epilepsy syndrome	0.0069	0.0208	CbGbCtD
Lamivudine—PGK1—hindbrain—epilepsy syndrome	0.00349	0.0634	CbGeAlD
Lamivudine—PCYT2—forebrain—epilepsy syndrome	0.00224	0.0408	CbGeAlD
Lamivudine—PGK1—brainstem—epilepsy syndrome	0.002	0.0363	CbGeAlD
Lamivudine—CMPK1—hindbrain—epilepsy syndrome	0.00178	0.0323	CbGeAlD
Lamivudine—NME2—hindbrain—epilepsy syndrome	0.00174	0.0316	CbGeAlD
Lamivudine—Cytarabine—NT5E—epilepsy syndrome	0.00158	0.818	CrCbGaD
Lamivudine—PCYT2—head—epilepsy syndrome	0.00129	0.0234	CbGeAlD
Lamivudine—PCYT2—nervous system—epilepsy syndrome	0.00122	0.0221	CbGeAlD
Lamivudine—PCYT2—central nervous system—epilepsy syndrome	0.00117	0.0213	CbGeAlD
Lamivudine—PGK1—head—epilepsy syndrome	0.0011	0.0201	CbGeAlD
Lamivudine—PGK1—nervous system—epilepsy syndrome	0.00105	0.019	CbGeAlD
Lamivudine—NME1—forebrain—epilepsy syndrome	0.00102	0.0186	CbGeAlD
Lamivudine—CMPK1—brainstem—epilepsy syndrome	0.00102	0.0185	CbGeAlD
Lamivudine—PGK1—central nervous system—epilepsy syndrome	0.00101	0.0183	CbGeAlD
Lamivudine—NME1-NME2—head—epilepsy syndrome	0.00101	0.0183	CbGeAlD
Lamivudine—NME2—brainstem—epilepsy syndrome	0.000997	0.0181	CbGeAlD
Lamivudine—SLC22A1—ganglion—epilepsy syndrome	0.000997	0.0181	CbGeAlD
Lamivudine—PGK1—cerebellum—epilepsy syndrome	0.000985	0.0179	CbGeAlD
Lamivudine—CMPK1—forebrain—epilepsy syndrome	0.000985	0.0179	CbGeAlD
Lamivudine—SLC22A3—tongue—epilepsy syndrome	0.000943	0.0171	CbGeAlD
Lamivudine—NT5C—head—epilepsy syndrome	0.000933	0.0169	CbGeAlD
Lamivudine—PCYT2—brain—epilepsy syndrome	0.000931	0.0169	CbGeAlD
Lamivudine—CMPK1—telencephalon—epilepsy syndrome	0.000906	0.0165	CbGeAlD
Lamivudine—NT5C—nervous system—epilepsy syndrome	0.000884	0.0161	CbGeAlD
Lamivudine—PCYT1A—head—epilepsy syndrome	0.000875	0.0159	CbGeAlD
Lamivudine—NT5C—central nervous system—epilepsy syndrome	0.000851	0.0155	CbGeAlD
Lamivudine—NT5C—cerebellum—epilepsy syndrome	0.000832	0.0151	CbGeAlD
Lamivudine—PCYT1A—nervous system—epilepsy syndrome	0.00083	0.0151	CbGeAlD
Lamivudine—PGK1—brain—epilepsy syndrome	0.0008	0.0145	CbGeAlD
Lamivudine—PCYT1A—central nervous system—epilepsy syndrome	0.000799	0.0145	CbGeAlD
Lamivudine—NT5C—brain—epilepsy syndrome	0.000676	0.0123	CbGeAlD
Lamivudine—CMPK1—midbrain—epilepsy syndrome	0.00065	0.0118	CbGeAlD
Lamivudine—CMPK1—spinal cord—epilepsy syndrome	0.000634	0.0115	CbGeAlD
Lamivudine—PCYT1A—brain—epilepsy syndrome	0.000634	0.0115	CbGeAlD
Lamivudine—NME1—head—epilepsy syndrome	0.000585	0.0106	CbGeAlD
Lamivudine—CMPK1—head—epilepsy syndrome	0.000564	0.0102	CbGeAlD
Lamivudine—NME1—nervous system—epilepsy syndrome	0.000555	0.0101	CbGeAlD
Lamivudine—NME2—head—epilepsy syndrome	0.000551	0.01	CbGeAlD
Lamivudine—CMPK1—nervous system—epilepsy syndrome	0.000535	0.00971	CbGeAlD
Lamivudine—NME1—central nervous system—epilepsy syndrome	0.000534	0.0097	CbGeAlD
Lamivudine—NME2—nervous system—epilepsy syndrome	0.000523	0.00949	CbGeAlD
Lamivudine—NME1—cerebellum—epilepsy syndrome	0.000522	0.00948	CbGeAlD
Lamivudine—CMPK1—central nervous system—epilepsy syndrome	0.000515	0.00935	CbGeAlD
Lamivudine—CMPK1—cerebellum—epilepsy syndrome	0.000503	0.00914	CbGeAlD
Lamivudine—NME2—central nervous system—epilepsy syndrome	0.000503	0.00914	CbGeAlD
Lamivudine—NME2—cerebellum—epilepsy syndrome	0.000492	0.00893	CbGeAlD
Lamivudine—NME1—Chlorprothixene—Midazolam—epilepsy syndrome	0.000471	0.289	CbGdCrCtD
Lamivudine—DCK—telencephalon—epilepsy syndrome	0.000451	0.00819	CbGeAlD
Lamivudine—NME1—Niclosamide—Clonazepam—epilepsy syndrome	0.00044	0.27	CbGdCrCtD
Lamivudine—NME1—brain—epilepsy syndrome	0.000424	0.0077	CbGeAlD
Lamivudine—NME1—Chlorprothixene—Diazepam—epilepsy syndrome	0.00042	0.258	CbGdCrCtD
Lamivudine—SLC22A1—forebrain—epilepsy syndrome	0.000418	0.0076	CbGeAlD
Lamivudine—CMPK1—brain—epilepsy syndrome	0.000409	0.00742	CbGeAlD
Lamivudine—NME2—brain—epilepsy syndrome	0.000399	0.00726	CbGeAlD
Lamivudine—ABCC4—forebrain—epilepsy syndrome	0.000388	0.00704	CbGeAlD
Lamivudine—SLC22A1—telencephalon—epilepsy syndrome	0.000385	0.00699	CbGeAlD
Lamivudine—DCK—medulla oblongata—epilepsy syndrome	0.000354	0.00644	CbGeAlD
Lamivudine—DCK—midbrain—epilepsy syndrome	0.000324	0.00588	CbGeAlD
Lamivudine—DCK—spinal cord—epilepsy syndrome	0.000316	0.00574	CbGeAlD
Lamivudine—ABCC1—telencephalon—epilepsy syndrome	0.000304	0.00552	CbGeAlD
Lamivudine—DCK—Niclosamide—Clonazepam—epilepsy syndrome	0.000299	0.184	CbGdCrCtD
Lamivudine—DCK—head—epilepsy syndrome	0.000281	0.0051	CbGeAlD
Lamivudine—ABCC3—head—epilepsy syndrome	0.000269	0.00488	CbGeAlD
Lamivudine—SLC22A6—brain—epilepsy syndrome	0.000266	0.00484	CbGeAlD
Lamivudine—DCK—nervous system—epilepsy syndrome	0.000266	0.00484	CbGeAlD
Lamivudine—DCK—central nervous system—epilepsy syndrome	0.000256	0.00466	CbGeAlD
Lamivudine—ABCC3—nervous system—epilepsy syndrome	0.000255	0.00463	CbGeAlD
Lamivudine—ABCG2—telencephalon—epilepsy syndrome	0.000252	0.00457	CbGeAlD
Lamivudine—DCK—cerebellum—epilepsy syndrome	0.00025	0.00455	CbGeAlD
Lamivudine—ABCC3—central nervous system—epilepsy syndrome	0.000245	0.00446	CbGeAlD
Lamivudine—SLC22A1—head—epilepsy syndrome	0.000239	0.00435	CbGeAlD
Lamivudine—SLC22A3—head—epilepsy syndrome	0.000229	0.00416	CbGeAlD
Lamivudine—SLC22A1—nervous system—epilepsy syndrome	0.000227	0.00412	CbGeAlD
Lamivudine—ABCC4—head—epilepsy syndrome	0.000222	0.00403	CbGeAlD
Lamivudine—SLC22A1—central nervous system—epilepsy syndrome	0.000219	0.00397	CbGeAlD
Lamivudine—SLC22A3—nervous system—epilepsy syndrome	0.000217	0.00394	CbGeAlD
Lamivudine—ABCC4—nervous system—epilepsy syndrome	0.00021	0.00382	CbGeAlD
Lamivudine—SLC22A3—central nervous system—epilepsy syndrome	0.000209	0.0038	CbGeAlD
Lamivudine—Zalcitabine—CYP2D6—epilepsy syndrome	0.000206	0.107	CrCbGaD
Lamivudine—DCK—brain—epilepsy syndrome	0.000203	0.0037	CbGeAlD
Lamivudine—ABCC4—central nervous system—epilepsy syndrome	0.000203	0.00368	CbGeAlD
Lamivudine—ABCG2—medulla oblongata—epilepsy syndrome	0.000198	0.00359	CbGeAlD
Lamivudine—ABCC3—brain—epilepsy syndrome	0.000195	0.00354	CbGeAlD
Lamivudine—ABCG2—midbrain—epilepsy syndrome	0.000181	0.00328	CbGeAlD
Lamivudine—ABCG2—spinal cord—epilepsy syndrome	0.000176	0.0032	CbGeAlD
Lamivudine—SLC22A1—brain—epilepsy syndrome	0.000174	0.00315	CbGeAlD
Lamivudine—ABCC1—cerebellum—epilepsy syndrome	0.000169	0.00307	CbGeAlD
Lamivudine—SLC22A3—brain—epilepsy syndrome	0.000166	0.00301	CbGeAlD
Lamivudine—ABCC4—brain—epilepsy syndrome	0.000161	0.00292	CbGeAlD
Lamivudine—Gemcitabine—ABCB1—epilepsy syndrome	0.000145	0.0751	CrCbGaD
Lamivudine—ABCG2—cerebellum—epilepsy syndrome	0.00014	0.00254	CbGeAlD
Lamivudine—ABCC1—brain—epilepsy syndrome	0.000137	0.00249	CbGeAlD
Lamivudine—ABCB1—forebrain—epilepsy syndrome	0.000135	0.00245	CbGeAlD
Lamivudine—ABCB1—telencephalon—epilepsy syndrome	0.000124	0.00225	CbGeAlD
Lamivudine—ABCG2—brain—epilepsy syndrome	0.000114	0.00206	CbGeAlD
Lamivudine—ABCB1—medulla oblongata—epilepsy syndrome	9.75e-05	0.00177	CbGeAlD
Lamivudine—ABCB1—midbrain—epilepsy syndrome	8.91e-05	0.00162	CbGeAlD
Lamivudine—ABCB1—spinal cord—epilepsy syndrome	8.69e-05	0.00158	CbGeAlD
Lamivudine—ABCB1—head—epilepsy syndrome	7.72e-05	0.0014	CbGeAlD
Lamivudine—ABCB1—nervous system—epilepsy syndrome	7.32e-05	0.00133	CbGeAlD
Lamivudine—ABCB1—central nervous system—epilepsy syndrome	7.05e-05	0.00128	CbGeAlD
Lamivudine—ABCB1—cerebellum—epilepsy syndrome	6.89e-05	0.00125	CbGeAlD
Lamivudine—ABCB1—brain—epilepsy syndrome	5.6e-05	0.00102	CbGeAlD
Lamivudine—Vomiting—Diazepam—epilepsy syndrome	4.01e-05	0.000219	CcSEcCtD
Lamivudine—Anorexia—Valproic Acid—epilepsy syndrome	4e-05	0.000219	CcSEcCtD
Lamivudine—Tremor—Gabapentin—epilepsy syndrome	3.99e-05	0.000218	CcSEcCtD
Lamivudine—Rash—Diazepam—epilepsy syndrome	3.98e-05	0.000217	CcSEcCtD
Lamivudine—Dermatitis—Diazepam—epilepsy syndrome	3.98e-05	0.000217	CcSEcCtD
Lamivudine—Chest pain—Pregabalin—epilepsy syndrome	3.96e-05	0.000216	CcSEcCtD
Lamivudine—Arthralgia—Pregabalin—epilepsy syndrome	3.96e-05	0.000216	CcSEcCtD
Lamivudine—Myalgia—Pregabalin—epilepsy syndrome	3.96e-05	0.000216	CcSEcCtD
Lamivudine—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.96e-05	0.000216	CcSEcCtD
Lamivudine—Dizziness—Zonisamide—epilepsy syndrome	3.95e-05	0.000216	CcSEcCtD
Lamivudine—Headache—Diazepam—epilepsy syndrome	3.95e-05	0.000216	CcSEcCtD
Lamivudine—Anxiety—Pregabalin—epilepsy syndrome	3.94e-05	0.000215	CcSEcCtD
Lamivudine—Diarrhoea—Clonazepam—epilepsy syndrome	3.94e-05	0.000215	CcSEcCtD
Lamivudine—Anaemia—Gabapentin—epilepsy syndrome	3.94e-05	0.000215	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.93e-05	0.000215	CcSEcCtD
Lamivudine—Hypotension—Valproic Acid—epilepsy syndrome	3.92e-05	0.000214	CcSEcCtD
Lamivudine—Asthenia—Carbamazepine—epilepsy syndrome	3.92e-05	0.000214	CcSEcCtD
Lamivudine—Diarrhoea—Phenytoin—epilepsy syndrome	3.92e-05	0.000214	CcSEcCtD
Lamivudine—Discomfort—Pregabalin—epilepsy syndrome	3.91e-05	0.000214	CcSEcCtD
Lamivudine—Nausea—Fosphenytoin—epilepsy syndrome	3.91e-05	0.000213	CcSEcCtD
Lamivudine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.9e-05	0.000213	CcSEcCtD
Lamivudine—Erythema multiforme—Topiramate—epilepsy syndrome	3.9e-05	0.000213	CcSEcCtD
Lamivudine—Angioedema—Gabapentin—epilepsy syndrome	3.9e-05	0.000213	CcSEcCtD
Lamivudine—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.89e-05	0.000213	CcSEcCtD
Lamivudine—Vomiting—Felbamate—epilepsy syndrome	3.88e-05	0.000212	CcSEcCtD
Lamivudine—Dry mouth—Pregabalin—epilepsy syndrome	3.87e-05	0.000211	CcSEcCtD
Lamivudine—Pruritus—Carbamazepine—epilepsy syndrome	3.87e-05	0.000211	CcSEcCtD
Lamivudine—Rash—Felbamate—epilepsy syndrome	3.85e-05	0.00021	CcSEcCtD
Lamivudine—Dermatitis—Felbamate—epilepsy syndrome	3.85e-05	0.00021	CcSEcCtD
Lamivudine—Malaise—Gabapentin—epilepsy syndrome	3.84e-05	0.00021	CcSEcCtD
Lamivudine—Vertigo—Gabapentin—epilepsy syndrome	3.83e-05	0.000209	CcSEcCtD
Lamivudine—Headache—Felbamate—epilepsy syndrome	3.83e-05	0.000209	CcSEcCtD
Lamivudine—Confusional state—Pregabalin—epilepsy syndrome	3.83e-05	0.000209	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.82e-05	0.000209	CcSEcCtD
Lamivudine—Syncope—Gabapentin—epilepsy syndrome	3.82e-05	0.000209	CcSEcCtD
Lamivudine—Leukopenia—Gabapentin—epilepsy syndrome	3.82e-05	0.000208	CcSEcCtD
Lamivudine—Dizziness—Clonazepam—epilepsy syndrome	3.81e-05	0.000208	CcSEcCtD
Lamivudine—Nausea—Vigabatrin—epilepsy syndrome	3.81e-05	0.000208	CcSEcCtD
Lamivudine—Vomiting—Zonisamide—epilepsy syndrome	3.8e-05	0.000208	CcSEcCtD
Lamivudine—Insomnia—Valproic Acid—epilepsy syndrome	3.8e-05	0.000207	CcSEcCtD
Lamivudine—Oedema—Pregabalin—epilepsy syndrome	3.79e-05	0.000207	CcSEcCtD
Lamivudine—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.79e-05	0.000207	CcSEcCtD
Lamivudine—Asthenia—Lamotrigine—epilepsy syndrome	3.79e-05	0.000207	CcSEcCtD
Lamivudine—Dizziness—Phenytoin—epilepsy syndrome	3.79e-05	0.000207	CcSEcCtD
Lamivudine—Rash—Zonisamide—epilepsy syndrome	3.77e-05	0.000206	CcSEcCtD
Lamivudine—Infection—Pregabalin—epilepsy syndrome	3.77e-05	0.000206	CcSEcCtD
Lamivudine—Paraesthesia—Valproic Acid—epilepsy syndrome	3.77e-05	0.000206	CcSEcCtD
Lamivudine—Dermatitis—Zonisamide—epilepsy syndrome	3.77e-05	0.000206	CcSEcCtD
Lamivudine—Dizziness—Oxcarbazepine—epilepsy syndrome	3.77e-05	0.000206	CcSEcCtD
Lamivudine—Nausea—Diazepam—epilepsy syndrome	3.75e-05	0.000205	CcSEcCtD
Lamivudine—Loss of consciousness—Gabapentin—epilepsy syndrome	3.75e-05	0.000205	CcSEcCtD
Lamivudine—Headache—Zonisamide—epilepsy syndrome	3.75e-05	0.000205	CcSEcCtD
Lamivudine—Dyspnoea—Valproic Acid—epilepsy syndrome	3.74e-05	0.000204	CcSEcCtD
Lamivudine—Diarrhoea—Carbamazepine—epilepsy syndrome	3.74e-05	0.000204	CcSEcCtD
Lamivudine—Pruritus—Lamotrigine—epilepsy syndrome	3.74e-05	0.000204	CcSEcCtD
Lamivudine—Shock—Pregabalin—epilepsy syndrome	3.73e-05	0.000204	CcSEcCtD
Lamivudine—Somnolence—Valproic Acid—epilepsy syndrome	3.73e-05	0.000204	CcSEcCtD
Lamivudine—Immune system disorder—Topiramate—epilepsy syndrome	3.72e-05	0.000203	CcSEcCtD
Lamivudine—Nervous system disorder—Pregabalin—epilepsy syndrome	3.72e-05	0.000203	CcSEcCtD
Lamivudine—Cough—Gabapentin—epilepsy syndrome	3.72e-05	0.000203	CcSEcCtD
Lamivudine—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.72e-05	0.000203	CcSEcCtD
Lamivudine—Mediastinal disorder—Topiramate—epilepsy syndrome	3.71e-05	0.000203	CcSEcCtD
Lamivudine—Chills—Topiramate—epilepsy syndrome	3.7e-05	0.000202	CcSEcCtD
Lamivudine—Dyspepsia—Valproic Acid—epilepsy syndrome	3.69e-05	0.000202	CcSEcCtD
Lamivudine—Convulsion—Gabapentin—epilepsy syndrome	3.69e-05	0.000202	CcSEcCtD
Lamivudine—Skin disorder—Pregabalin—epilepsy syndrome	3.69e-05	0.000201	CcSEcCtD
Lamivudine—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.67e-05	0.0002	CcSEcCtD
Lamivudine—Vomiting—Clonazepam—epilepsy syndrome	3.66e-05	0.0002	CcSEcCtD
Lamivudine—Decreased appetite—Valproic Acid—epilepsy syndrome	3.65e-05	0.000199	CcSEcCtD
Lamivudine—Alopecia—Topiramate—epilepsy syndrome	3.64e-05	0.000199	CcSEcCtD
Lamivudine—Vomiting—Phenytoin—epilepsy syndrome	3.64e-05	0.000199	CcSEcCtD
Lamivudine—Rash—Clonazepam—epilepsy syndrome	3.63e-05	0.000198	CcSEcCtD
Lamivudine—Dermatitis—Clonazepam—epilepsy syndrome	3.63e-05	0.000198	CcSEcCtD
Lamivudine—Chest pain—Gabapentin—epilepsy syndrome	3.63e-05	0.000198	CcSEcCtD
Lamivudine—Arthralgia—Gabapentin—epilepsy syndrome	3.63e-05	0.000198	CcSEcCtD
Lamivudine—Myalgia—Gabapentin—epilepsy syndrome	3.63e-05	0.000198	CcSEcCtD
Lamivudine—Nausea—Felbamate—epilepsy syndrome	3.63e-05	0.000198	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.62e-05	0.000198	CcSEcCtD
Lamivudine—Vomiting—Oxcarbazepine—epilepsy syndrome	3.62e-05	0.000198	CcSEcCtD
Lamivudine—Fatigue—Valproic Acid—epilepsy syndrome	3.62e-05	0.000198	CcSEcCtD
Lamivudine—Anxiety—Gabapentin—epilepsy syndrome	3.62e-05	0.000198	CcSEcCtD
Lamivudine—Anorexia—Pregabalin—epilepsy syndrome	3.62e-05	0.000198	CcSEcCtD
Lamivudine—Dizziness—Carbamazepine—epilepsy syndrome	3.61e-05	0.000197	CcSEcCtD
Lamivudine—Diarrhoea—Lamotrigine—epilepsy syndrome	3.61e-05	0.000197	CcSEcCtD
Lamivudine—Headache—Clonazepam—epilepsy syndrome	3.61e-05	0.000197	CcSEcCtD
Lamivudine—Rash—Phenytoin—epilepsy syndrome	3.61e-05	0.000197	CcSEcCtD
Lamivudine—Dermatitis—Phenytoin—epilepsy syndrome	3.61e-05	0.000197	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.6e-05	0.000197	CcSEcCtD
Lamivudine—Rash—Oxcarbazepine—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Lamivudine—Constipation—Valproic Acid—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Lamivudine—Pain—Valproic Acid—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Lamivudine—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Lamivudine—Headache—Phenytoin—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Lamivudine—Malnutrition—Topiramate—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Lamivudine—Erythema—Topiramate—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Lamivudine—Discomfort—Gabapentin—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Lamivudine—Headache—Oxcarbazepine—epilepsy syndrome	3.57e-05	0.000195	CcSEcCtD
Lamivudine—Nausea—Zonisamide—epilepsy syndrome	3.55e-05	0.000194	CcSEcCtD
Lamivudine—Dry mouth—Gabapentin—epilepsy syndrome	3.55e-05	0.000194	CcSEcCtD
Lamivudine—Hypotension—Pregabalin—epilepsy syndrome	3.55e-05	0.000194	CcSEcCtD
Lamivudine—Flatulence—Topiramate—epilepsy syndrome	3.53e-05	0.000193	CcSEcCtD
Lamivudine—Tension—Topiramate—epilepsy syndrome	3.52e-05	0.000192	CcSEcCtD
Lamivudine—Dysgeusia—Topiramate—epilepsy syndrome	3.51e-05	0.000192	CcSEcCtD
Lamivudine—Confusional state—Gabapentin—epilepsy syndrome	3.51e-05	0.000192	CcSEcCtD
Lamivudine—Dizziness—Lamotrigine—epilepsy syndrome	3.49e-05	0.000191	CcSEcCtD
Lamivudine—Nervousness—Topiramate—epilepsy syndrome	3.48e-05	0.00019	CcSEcCtD
Lamivudine—Oedema—Gabapentin—epilepsy syndrome	3.48e-05	0.00019	CcSEcCtD
Lamivudine—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.48e-05	0.00019	CcSEcCtD
Lamivudine—Vomiting—Carbamazepine—epilepsy syndrome	3.47e-05	0.00019	CcSEcCtD
Lamivudine—Back pain—Topiramate—epilepsy syndrome	3.47e-05	0.000189	CcSEcCtD
Lamivudine—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.46e-05	0.000189	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.46e-05	0.000189	CcSEcCtD
Lamivudine—Infection—Gabapentin—epilepsy syndrome	3.46e-05	0.000189	CcSEcCtD
Lamivudine—Muscle spasms—Topiramate—epilepsy syndrome	3.45e-05	0.000188	CcSEcCtD
Lamivudine—Rash—Carbamazepine—epilepsy syndrome	3.45e-05	0.000188	CcSEcCtD
Lamivudine—Dermatitis—Carbamazepine—epilepsy syndrome	3.44e-05	0.000188	CcSEcCtD
Lamivudine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.43e-05	0.000187	CcSEcCtD
Lamivudine—Insomnia—Pregabalin—epilepsy syndrome	3.43e-05	0.000187	CcSEcCtD
Lamivudine—Nausea—Clonazepam—epilepsy syndrome	3.42e-05	0.000187	CcSEcCtD
Lamivudine—Headache—Carbamazepine—epilepsy syndrome	3.42e-05	0.000187	CcSEcCtD
Lamivudine—Shock—Gabapentin—epilepsy syndrome	3.42e-05	0.000187	CcSEcCtD
Lamivudine—Nervous system disorder—Gabapentin—epilepsy syndrome	3.41e-05	0.000186	CcSEcCtD
Lamivudine—Paraesthesia—Pregabalin—epilepsy syndrome	3.41e-05	0.000186	CcSEcCtD
Lamivudine—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.41e-05	0.000186	CcSEcCtD
Lamivudine—Nausea—Phenytoin—epilepsy syndrome	3.4e-05	0.000186	CcSEcCtD
Lamivudine—Dyspnoea—Pregabalin—epilepsy syndrome	3.38e-05	0.000185	CcSEcCtD
Lamivudine—Nausea—Oxcarbazepine—epilepsy syndrome	3.38e-05	0.000185	CcSEcCtD
Lamivudine—Skin disorder—Gabapentin—epilepsy syndrome	3.38e-05	0.000185	CcSEcCtD
Lamivudine—Somnolence—Pregabalin—epilepsy syndrome	3.37e-05	0.000184	CcSEcCtD
Lamivudine—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.36e-05	0.000184	CcSEcCtD
Lamivudine—Tremor—Topiramate—epilepsy syndrome	3.36e-05	0.000184	CcSEcCtD
Lamivudine—Vomiting—Lamotrigine—epilepsy syndrome	3.36e-05	0.000183	CcSEcCtD
Lamivudine—Urticaria—Valproic Acid—epilepsy syndrome	3.33e-05	0.000182	CcSEcCtD
Lamivudine—Rash—Lamotrigine—epilepsy syndrome	3.33e-05	0.000182	CcSEcCtD
Lamivudine—Ill-defined disorder—Topiramate—epilepsy syndrome	3.33e-05	0.000182	CcSEcCtD
Lamivudine—Dermatitis—Lamotrigine—epilepsy syndrome	3.33e-05	0.000182	CcSEcCtD
Lamivudine—Abdominal pain—Valproic Acid—epilepsy syndrome	3.32e-05	0.000181	CcSEcCtD
Lamivudine—Body temperature increased—Valproic Acid—epilepsy syndrome	3.32e-05	0.000181	CcSEcCtD
Lamivudine—Anorexia—Gabapentin—epilepsy syndrome	3.32e-05	0.000181	CcSEcCtD
Lamivudine—Anaemia—Topiramate—epilepsy syndrome	3.32e-05	0.000181	CcSEcCtD
Lamivudine—Headache—Lamotrigine—epilepsy syndrome	3.31e-05	0.000181	CcSEcCtD
Lamivudine—Decreased appetite—Pregabalin—epilepsy syndrome	3.3e-05	0.00018	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.28e-05	0.000179	CcSEcCtD
Lamivudine—Fatigue—Pregabalin—epilepsy syndrome	3.27e-05	0.000179	CcSEcCtD
Lamivudine—Hypotension—Gabapentin—epilepsy syndrome	3.25e-05	0.000178	CcSEcCtD
Lamivudine—Nausea—Carbamazepine—epilepsy syndrome	3.25e-05	0.000177	CcSEcCtD
Lamivudine—Pain—Pregabalin—epilepsy syndrome	3.24e-05	0.000177	CcSEcCtD
Lamivudine—Constipation—Pregabalin—epilepsy syndrome	3.24e-05	0.000177	CcSEcCtD
Lamivudine—Malaise—Topiramate—epilepsy syndrome	3.23e-05	0.000177	CcSEcCtD
Lamivudine—Vertigo—Topiramate—epilepsy syndrome	3.22e-05	0.000176	CcSEcCtD
Lamivudine—Syncope—Topiramate—epilepsy syndrome	3.22e-05	0.000176	CcSEcCtD
Lamivudine—Leukopenia—Topiramate—epilepsy syndrome	3.21e-05	0.000175	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.17e-05	0.000173	CcSEcCtD
Lamivudine—Loss of consciousness—Topiramate—epilepsy syndrome	3.15e-05	0.000172	CcSEcCtD
Lamivudine—Insomnia—Gabapentin—epilepsy syndrome	3.15e-05	0.000172	CcSEcCtD
Lamivudine—Nausea—Lamotrigine—epilepsy syndrome	3.14e-05	0.000171	CcSEcCtD
Lamivudine—Cough—Topiramate—epilepsy syndrome	3.13e-05	0.000171	CcSEcCtD
Lamivudine—Feeling abnormal—Pregabalin—epilepsy syndrome	3.13e-05	0.000171	CcSEcCtD
Lamivudine—Paraesthesia—Gabapentin—epilepsy syndrome	3.12e-05	0.000171	CcSEcCtD
Lamivudine—Convulsion—Topiramate—epilepsy syndrome	3.11e-05	0.00017	CcSEcCtD
Lamivudine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.1e-05	0.000169	CcSEcCtD
Lamivudine—Dyspnoea—Gabapentin—epilepsy syndrome	3.1e-05	0.000169	CcSEcCtD
Lamivudine—Somnolence—Gabapentin—epilepsy syndrome	3.09e-05	0.000169	CcSEcCtD
Lamivudine—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.09e-05	0.000169	CcSEcCtD
Lamivudine—Dyspepsia—Gabapentin—epilepsy syndrome	3.06e-05	0.000167	CcSEcCtD
Lamivudine—Chest pain—Topiramate—epilepsy syndrome	3.05e-05	0.000167	CcSEcCtD
Lamivudine—Arthralgia—Topiramate—epilepsy syndrome	3.05e-05	0.000167	CcSEcCtD
Lamivudine—Myalgia—Topiramate—epilepsy syndrome	3.05e-05	0.000167	CcSEcCtD
Lamivudine—Anxiety—Topiramate—epilepsy syndrome	3.04e-05	0.000166	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.03e-05	0.000166	CcSEcCtD
Lamivudine—Decreased appetite—Gabapentin—epilepsy syndrome	3.02e-05	0.000165	CcSEcCtD
Lamivudine—Discomfort—Topiramate—epilepsy syndrome	3.02e-05	0.000165	CcSEcCtD
Lamivudine—Urticaria—Pregabalin—epilepsy syndrome	3.01e-05	0.000165	CcSEcCtD
Lamivudine—Asthenia—Valproic Acid—epilepsy syndrome	3.01e-05	0.000164	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3e-05	0.000164	CcSEcCtD
Lamivudine—Fatigue—Gabapentin—epilepsy syndrome	3e-05	0.000164	CcSEcCtD
Lamivudine—Abdominal pain—Pregabalin—epilepsy syndrome	3e-05	0.000164	CcSEcCtD
Lamivudine—Body temperature increased—Pregabalin—epilepsy syndrome	3e-05	0.000164	CcSEcCtD
Lamivudine—Dry mouth—Topiramate—epilepsy syndrome	2.99e-05	0.000163	CcSEcCtD
Lamivudine—Pain—Gabapentin—epilepsy syndrome	2.98e-05	0.000163	CcSEcCtD
Lamivudine—Constipation—Gabapentin—epilepsy syndrome	2.98e-05	0.000163	CcSEcCtD
Lamivudine—Pruritus—Valproic Acid—epilepsy syndrome	2.97e-05	0.000162	CcSEcCtD
Lamivudine—Confusional state—Topiramate—epilepsy syndrome	2.95e-05	0.000161	CcSEcCtD
Lamivudine—Oedema—Topiramate—epilepsy syndrome	2.93e-05	0.00016	CcSEcCtD
Lamivudine—Infection—Topiramate—epilepsy syndrome	2.91e-05	0.000159	CcSEcCtD
Lamivudine—Shock—Topiramate—epilepsy syndrome	2.88e-05	0.000157	CcSEcCtD
Lamivudine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.87e-05	0.000157	CcSEcCtD
Lamivudine—Nervous system disorder—Topiramate—epilepsy syndrome	2.87e-05	0.000157	CcSEcCtD
Lamivudine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.87e-05	0.000157	CcSEcCtD
Lamivudine—Thrombocytopenia—Topiramate—epilepsy syndrome	2.87e-05	0.000157	CcSEcCtD
Lamivudine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.85e-05	0.000155	CcSEcCtD
Lamivudine—Skin disorder—Topiramate—epilepsy syndrome	2.84e-05	0.000155	CcSEcCtD
Lamivudine—Hyperhidrosis—Topiramate—epilepsy syndrome	2.83e-05	0.000155	CcSEcCtD
Lamivudine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.8e-05	0.000153	CcSEcCtD
Lamivudine—Anorexia—Topiramate—epilepsy syndrome	2.79e-05	0.000152	CcSEcCtD
Lamivudine—Dizziness—Valproic Acid—epilepsy syndrome	2.78e-05	0.000152	CcSEcCtD
Lamivudine—Urticaria—Gabapentin—epilepsy syndrome	2.76e-05	0.000151	CcSEcCtD
Lamivudine—Body temperature increased—Gabapentin—epilepsy syndrome	2.75e-05	0.00015	CcSEcCtD
Lamivudine—Abdominal pain—Gabapentin—epilepsy syndrome	2.75e-05	0.00015	CcSEcCtD
Lamivudine—Hypotension—Topiramate—epilepsy syndrome	2.74e-05	0.000149	CcSEcCtD
Lamivudine—Asthenia—Pregabalin—epilepsy syndrome	2.72e-05	0.000149	CcSEcCtD
Lamivudine—Pruritus—Pregabalin—epilepsy syndrome	2.68e-05	0.000147	CcSEcCtD
Lamivudine—Vomiting—Valproic Acid—epilepsy syndrome	2.67e-05	0.000146	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.67e-05	0.000146	CcSEcCtD
Lamivudine—Insomnia—Topiramate—epilepsy syndrome	2.65e-05	0.000145	CcSEcCtD
Lamivudine—Rash—Valproic Acid—epilepsy syndrome	2.65e-05	0.000145	CcSEcCtD
Lamivudine—Dermatitis—Valproic Acid—epilepsy syndrome	2.64e-05	0.000144	CcSEcCtD
Lamivudine—Headache—Valproic Acid—epilepsy syndrome	2.63e-05	0.000144	CcSEcCtD
Lamivudine—Paraesthesia—Topiramate—epilepsy syndrome	2.63e-05	0.000144	CcSEcCtD
Lamivudine—Dyspnoea—Topiramate—epilepsy syndrome	2.61e-05	0.000143	CcSEcCtD
Lamivudine—Somnolence—Topiramate—epilepsy syndrome	2.6e-05	0.000142	CcSEcCtD
Lamivudine—Diarrhoea—Pregabalin—epilepsy syndrome	2.6e-05	0.000142	CcSEcCtD
Lamivudine—Dyspepsia—Topiramate—epilepsy syndrome	2.58e-05	0.000141	CcSEcCtD
Lamivudine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.56e-05	0.00014	CcSEcCtD
Lamivudine—Decreased appetite—Topiramate—epilepsy syndrome	2.54e-05	0.000139	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.53e-05	0.000138	CcSEcCtD
Lamivudine—Fatigue—Topiramate—epilepsy syndrome	2.52e-05	0.000138	CcSEcCtD
Lamivudine—Dizziness—Pregabalin—epilepsy syndrome	2.51e-05	0.000137	CcSEcCtD
Lamivudine—Constipation—Topiramate—epilepsy syndrome	2.5e-05	0.000137	CcSEcCtD
Lamivudine—Pain—Topiramate—epilepsy syndrome	2.5e-05	0.000137	CcSEcCtD
Lamivudine—Asthenia—Gabapentin—epilepsy syndrome	2.5e-05	0.000136	CcSEcCtD
Lamivudine—Nausea—Valproic Acid—epilepsy syndrome	2.49e-05	0.000136	CcSEcCtD
Lamivudine—Pruritus—Gabapentin—epilepsy syndrome	2.46e-05	0.000134	CcSEcCtD
Lamivudine—Vomiting—Pregabalin—epilepsy syndrome	2.41e-05	0.000132	CcSEcCtD
Lamivudine—Feeling abnormal—Topiramate—epilepsy syndrome	2.41e-05	0.000132	CcSEcCtD
Lamivudine—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.39e-05	0.000131	CcSEcCtD
Lamivudine—Rash—Pregabalin—epilepsy syndrome	2.39e-05	0.000131	CcSEcCtD
Lamivudine—Dermatitis—Pregabalin—epilepsy syndrome	2.39e-05	0.000131	CcSEcCtD
Lamivudine—Diarrhoea—Gabapentin—epilepsy syndrome	2.38e-05	0.00013	CcSEcCtD
Lamivudine—Headache—Pregabalin—epilepsy syndrome	2.38e-05	0.00013	CcSEcCtD
Lamivudine—Urticaria—Topiramate—epilepsy syndrome	2.33e-05	0.000127	CcSEcCtD
Lamivudine—Abdominal pain—Topiramate—epilepsy syndrome	2.31e-05	0.000126	CcSEcCtD
Lamivudine—Body temperature increased—Topiramate—epilepsy syndrome	2.31e-05	0.000126	CcSEcCtD
Lamivudine—Dizziness—Gabapentin—epilepsy syndrome	2.3e-05	0.000126	CcSEcCtD
Lamivudine—Nausea—Pregabalin—epilepsy syndrome	2.25e-05	0.000123	CcSEcCtD
Lamivudine—Vomiting—Gabapentin—epilepsy syndrome	2.21e-05	0.000121	CcSEcCtD
Lamivudine—Rash—Gabapentin—epilepsy syndrome	2.19e-05	0.00012	CcSEcCtD
Lamivudine—Dermatitis—Gabapentin—epilepsy syndrome	2.19e-05	0.00012	CcSEcCtD
Lamivudine—Headache—Gabapentin—epilepsy syndrome	2.18e-05	0.000119	CcSEcCtD
Lamivudine—Hypersensitivity—Topiramate—epilepsy syndrome	2.16e-05	0.000118	CcSEcCtD
Lamivudine—Asthenia—Topiramate—epilepsy syndrome	2.1e-05	0.000115	CcSEcCtD
Lamivudine—Pruritus—Topiramate—epilepsy syndrome	2.07e-05	0.000113	CcSEcCtD
Lamivudine—Nausea—Gabapentin—epilepsy syndrome	2.07e-05	0.000113	CcSEcCtD
Lamivudine—Diarrhoea—Topiramate—epilepsy syndrome	2e-05	0.000109	CcSEcCtD
Lamivudine—Dizziness—Topiramate—epilepsy syndrome	1.94e-05	0.000106	CcSEcCtD
Lamivudine—Vomiting—Topiramate—epilepsy syndrome	1.86e-05	0.000102	CcSEcCtD
Lamivudine—Rash—Topiramate—epilepsy syndrome	1.85e-05	0.000101	CcSEcCtD
Lamivudine—Dermatitis—Topiramate—epilepsy syndrome	1.84e-05	0.000101	CcSEcCtD
Lamivudine—Headache—Topiramate—epilepsy syndrome	1.83e-05	0.0001	CcSEcCtD
Lamivudine—Nausea—Topiramate—epilepsy syndrome	1.74e-05	9.5e-05	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—CYP2D6—epilepsy syndrome	5.39e-06	4.29e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CACNA1D—epilepsy syndrome	5.38e-06	4.28e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.38e-06	4.28e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.37e-06	4.27e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.32e-06	4.23e-05	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	5.31e-06	4.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CA4—epilepsy syndrome	5.31e-06	4.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—QDPR—epilepsy syndrome	5.31e-06	4.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	5.31e-06	4.22e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AQP1—epilepsy syndrome	5.3e-06	4.22e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AQP1—epilepsy syndrome	5.25e-06	4.17e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.21e-06	4.14e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.15e-06	4.1e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.14e-06	4.09e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ALB—epilepsy syndrome	5.13e-06	4.08e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ADRA2A—epilepsy syndrome	5.13e-06	4.08e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—BCHE—epilepsy syndrome	5.11e-06	4.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.07e-06	4.04e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TXNRD1—epilepsy syndrome	5.04e-06	4.01e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5e-06	3.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—COX3—epilepsy syndrome	4.99e-06	3.97e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.97e-06	3.95e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.97e-06	3.95e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AGT—epilepsy syndrome	4.97e-06	3.95e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.96e-06	3.95e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP2D6—epilepsy syndrome	4.95e-06	3.94e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	4.93e-06	3.92e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AQP1—epilepsy syndrome	4.89e-06	3.89e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SLC2A1—epilepsy syndrome	4.87e-06	3.88e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—APOE—epilepsy syndrome	4.87e-06	3.87e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—epilepsy syndrome	4.86e-06	3.87e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PLCB1—epilepsy syndrome	4.82e-06	3.84e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TH—epilepsy syndrome	4.8e-06	3.82e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.8e-06	3.82e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CHRM3—epilepsy syndrome	4.79e-06	3.81e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—KCNJ11—epilepsy syndrome	4.79e-06	3.81e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	4.76e-06	3.79e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CHRM3—epilepsy syndrome	4.74e-06	3.77e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—KCNJ11—epilepsy syndrome	4.74e-06	3.77e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	4.73e-06	3.76e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—KCNB1—epilepsy syndrome	4.73e-06	3.76e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PFKL—epilepsy syndrome	4.73e-06	3.76e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	4.73e-06	3.76e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	4.73e-06	3.76e-05	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.72e-06	3.76e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ADRA2A—epilepsy syndrome	4.72e-06	3.75e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—BCHE—epilepsy syndrome	4.7e-06	3.74e-05	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AKT1—epilepsy syndrome	4.65e-06	3.7e-05	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AKT1—epilepsy syndrome	4.65e-06	3.7e-05	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AKT1—epilepsy syndrome	4.65e-06	3.7e-05	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	4.56e-06	3.63e-05	CbGpPWpGaD
Lamivudine—PGK1—Disease—AKT1—epilepsy syndrome	4.53e-06	3.6e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	4.51e-06	3.59e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC2A1—epilepsy syndrome	4.48e-06	3.56e-05	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.44e-06	3.53e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCG2—epilepsy syndrome	4.44e-06	3.53e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PLCB1—epilepsy syndrome	4.43e-06	3.53e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CHRM3—epilepsy syndrome	4.42e-06	3.52e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—KCNJ11—epilepsy syndrome	4.42e-06	3.52e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TH—epilepsy syndrome	4.42e-06	3.51e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	4.4e-06	3.5e-05	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	4.38e-06	3.48e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.35e-06	3.46e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP2C19—epilepsy syndrome	4.33e-06	3.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ATIC—epilepsy syndrome	4.33e-06	3.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NEU1—epilepsy syndrome	4.33e-06	3.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—UPB1—epilepsy syndrome	4.33e-06	3.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	4.3e-06	3.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP11A1—epilepsy syndrome	4.3e-06	3.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.27e-06	3.4e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SLC2A1—epilepsy syndrome	4.19e-06	3.33e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—POMC—epilepsy syndrome	4.18e-06	3.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	4.16e-06	3.31e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—JUNB—epilepsy syndrome	4.16e-06	3.31e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS1—epilepsy syndrome	4.13e-06	3.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	4.08e-06	3.25e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	4.02e-06	3.2e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GBE1—epilepsy syndrome	4.02e-06	3.2e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—HMOX1—epilepsy syndrome	4.01e-06	3.19e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CAT—epilepsy syndrome	3.96e-06	3.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HBEGF—epilepsy syndrome	3.94e-06	3.14e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.89e-06	3.1e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP2D6—epilepsy syndrome	3.88e-06	3.09e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	3.88e-06	3.09e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT3—epilepsy syndrome	3.87e-06	3.08e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCG2—epilepsy syndrome	3.87e-06	3.08e-05	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.87e-06	3.08e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ABCB1—epilepsy syndrome	3.85e-06	3.06e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ALB—epilepsy syndrome	3.81e-06	3.03e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP2C19—epilepsy syndrome	3.81e-06	3.03e-05	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—epilepsy syndrome	3.79e-06	3.02e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP11A1—epilepsy syndrome	3.78e-06	3.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ASAH1—epilepsy syndrome	3.78e-06	3.01e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ADAM10—epilepsy syndrome	3.78e-06	3.01e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP2C19—epilepsy syndrome	3.77e-06	3e-05	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.75e-06	2.98e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP11A1—epilepsy syndrome	3.75e-06	2.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.74e-06	2.97e-05	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.7e-06	2.94e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ADRA2A—epilepsy syndrome	3.7e-06	2.94e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—HMOX1—epilepsy syndrome	3.69e-06	2.93e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—BCHE—epilepsy syndrome	3.68e-06	2.93e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—STXBP1—epilepsy syndrome	3.68e-06	2.93e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CAT—epilepsy syndrome	3.64e-06	2.89e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—SRC—epilepsy syndrome	3.63e-06	2.89e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCG2—epilepsy syndrome	3.6e-06	2.87e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	3.6e-06	2.87e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALAD—epilepsy syndrome	3.58e-06	2.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NT5E—epilepsy syndrome	3.58e-06	2.85e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GPX1—epilepsy syndrome	3.58e-06	2.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.57e-06	2.84e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ABCB1—epilepsy syndrome	3.54e-06	2.81e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—epilepsy syndrome	3.54e-06	2.81e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDC42—epilepsy syndrome	3.53e-06	2.81e-05	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—epilepsy syndrome	3.53e-06	2.8e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2C19—epilepsy syndrome	3.51e-06	2.79e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC2A1—epilepsy syndrome	3.51e-06	2.79e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	3.5e-06	2.78e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP11A1—epilepsy syndrome	3.49e-06	2.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PLCB1—epilepsy syndrome	3.47e-06	2.76e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TH—epilepsy syndrome	3.46e-06	2.75e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	3.42e-06	2.72e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	3.42e-06	2.72e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	3.42e-06	2.72e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.41e-06	2.71e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	3.38e-06	2.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	3.35e-06	2.66e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—epilepsy syndrome	3.34e-06	2.65e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GPX1—epilepsy syndrome	3.29e-06	2.62e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ADSL—epilepsy syndrome	3.28e-06	2.61e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.26e-06	2.59e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	3.25e-06	2.59e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—BCHE—epilepsy syndrome	3.24e-06	2.58e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HES1—epilepsy syndrome	3.23e-06	2.57e-05	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—epilepsy syndrome	3.22e-06	2.57e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.22e-06	2.56e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	3.22e-06	2.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GLUL—epilepsy syndrome	3.22e-06	2.56e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—BCHE—epilepsy syndrome	3.2e-06	2.55e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	3.16e-06	2.51e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2D6—epilepsy syndrome	3.15e-06	2.51e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FYN—epilepsy syndrome	3.14e-06	2.5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	3.14e-06	2.5e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AGT—epilepsy syndrome	3.14e-06	2.5e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—H2AFX—epilepsy syndrome	3.13e-06	2.49e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	3.09e-06	2.46e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOE—epilepsy syndrome	3.07e-06	2.45e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	3.06e-06	2.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	3.06e-06	2.43e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PLCB1—epilepsy syndrome	3.06e-06	2.43e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TH—epilepsy syndrome	3.04e-06	2.42e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	3.02e-06	2.41e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—YWHAZ—epilepsy syndrome	3.02e-06	2.4e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TH—epilepsy syndrome	3.01e-06	2.4e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3e-06	2.39e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ADRA2A—epilepsy syndrome	3e-06	2.39e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—BCHE—epilepsy syndrome	2.99e-06	2.38e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	2.95e-06	2.35e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.93e-06	2.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.91e-06	2.31e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CCR5—epilepsy syndrome	2.91e-06	2.31e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HMOX1—epilepsy syndrome	2.89e-06	2.3e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AGT—epilepsy syndrome	2.88e-06	2.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AQP1—epilepsy syndrome	2.87e-06	2.28e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	2.85e-06	2.27e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CAT—epilepsy syndrome	2.85e-06	2.27e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOE—epilepsy syndrome	2.83e-06	2.25e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	2.82e-06	2.24e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TH—epilepsy syndrome	2.81e-06	2.23e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCB1—epilepsy syndrome	2.77e-06	2.2e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TSC2—epilepsy syndrome	2.7e-06	2.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOE—epilepsy syndrome	2.64e-06	2.1e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—POMC—epilepsy syndrome	2.64e-06	2.1e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.62e-06	2.08e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CHRM3—epilepsy syndrome	2.59e-06	2.06e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	2.59e-06	2.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GPX1—epilepsy syndrome	2.58e-06	2.05e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HMOX1—epilepsy syndrome	2.54e-06	2.02e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	2.51e-06	2e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CAT—epilepsy syndrome	2.51e-06	1.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6ST—epilepsy syndrome	2.48e-06	1.98e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CAT—epilepsy syndrome	2.48e-06	1.97e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS2—epilepsy syndrome	2.46e-06	1.96e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—epilepsy syndrome	2.44e-06	1.94e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ABCB1—epilepsy syndrome	2.44e-06	1.94e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—POMC—epilepsy syndrome	2.43e-06	1.93e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	2.41e-06	1.92e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—epilepsy syndrome	2.41e-06	1.92e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	2.34e-06	1.86e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CAT—epilepsy syndrome	2.31e-06	1.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GPX1—epilepsy syndrome	2.27e-06	1.8e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AGT—epilepsy syndrome	2.26e-06	1.8e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—epilepsy syndrome	2.26e-06	1.79e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	2.25e-06	1.79e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GPX1—epilepsy syndrome	2.24e-06	1.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOE—epilepsy syndrome	2.21e-06	1.76e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—epilepsy syndrome	2.21e-06	1.76e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.11e-06	1.68e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—epilepsy syndrome	2.11e-06	1.68e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GPX1—epilepsy syndrome	2.09e-06	1.66e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.06e-06	1.64e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.05e-06	1.63e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGF2—epilepsy syndrome	2.01e-06	1.6e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AGT—epilepsy syndrome	1.99e-06	1.58e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AGT—epilepsy syndrome	1.97e-06	1.57e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.95e-06	1.55e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOE—epilepsy syndrome	1.95e-06	1.55e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—epilepsy syndrome	1.94e-06	1.54e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOE—epilepsy syndrome	1.93e-06	1.53e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—POMC—epilepsy syndrome	1.9e-06	1.51e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.85e-06	1.47e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AGT—epilepsy syndrome	1.83e-06	1.46e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTOR—epilepsy syndrome	1.83e-06	1.45e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—epilepsy syndrome	1.81e-06	1.44e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOE—epilepsy syndrome	1.8e-06	1.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.76e-06	1.4e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.76e-06	1.4e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.75e-06	1.39e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—epilepsy syndrome	1.73e-06	1.38e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—epilepsy syndrome	1.68e-06	1.33e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—POMC—epilepsy syndrome	1.67e-06	1.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.67e-06	1.33e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—POMC—epilepsy syndrome	1.66e-06	1.32e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.65e-06	1.31e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TH—epilepsy syndrome	1.65e-06	1.31e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—POMC—epilepsy syndrome	1.54e-06	1.23e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—epilepsy syndrome	1.53e-06	1.21e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—epilepsy syndrome	1.52e-06	1.21e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—epilepsy syndrome	1.51e-06	1.2e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SRC—epilepsy syndrome	1.46e-06	1.17e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—epilepsy syndrome	1.41e-06	1.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.37e-06	1.09e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CAT—epilepsy syndrome	1.36e-06	1.08e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.33e-06	1.06e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	1.32e-06	1.05e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.23e-06	9.79e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.23e-06	9.75e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AGT—epilepsy syndrome	1.07e-06	8.55e-06	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—epilepsy syndrome	1.06e-06	8.42e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOE—epilepsy syndrome	1.05e-06	8.38e-06	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—epilepsy syndrome	9.73e-07	7.74e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—epilepsy syndrome	9.1e-07	7.24e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—POMC—epilepsy syndrome	9.05e-07	7.2e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—epilepsy syndrome	8.25e-07	6.56e-06	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—epilepsy syndrome	7.62e-07	6.06e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	7.22e-07	5.74e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—epilepsy syndrome	6.71e-07	5.34e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—epilepsy syndrome	6.64e-07	5.28e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—epilepsy syndrome	6.19e-07	4.92e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—epilepsy syndrome	3.63e-07	2.89e-06	CbGpPWpGaD
